Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) dropped 3.8% during trading on Tuesday . The company traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Price Performance
The stock has a 50 day moving average price of C$0.26 and a two-hundred day moving average price of C$0.26. The company has a market capitalization of C$52.28 million and a PE ratio of -0.37. The company has a debt-to-equity ratio of 35.45, a quick ratio of 2.61 and a current ratio of 2.97.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Recommended Stories
- Five stocks we like better than Emerald Health Therapeutics
- Stock Average Calculator
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Lockheed Martin Stock Aims for a Fresh All-Time High
- What Do S&P 500 Stocks Tell Investors About the Market?
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
